| Code | CSB-RA227095A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| IF | 1:20-1:200 |
RNF20, also known as BRE1A, functions as an E3 ubiquitin-protein ligase that plays a central role in chromatin regulation through monoubiquitination of histone H2B. This modification serves as a critical epigenetic mark that influences transcriptional elongation, DNA damage response, and genome stability. Researchers investigating chromatin dynamics, transcriptional regulation, and cancer biology frequently target RNF20 due to its involvement in tumor suppression pathways and its emerging connections to developmental processes.
This recombinant monoclonal antibody, generated from clone 2H12 in rabbit host, offers the reproducibility and consistency that demanding experimental workflows require. Because the antibody sequence is defined and production occurs through recombinant expression, researchers can expect minimal lot-to-lot variation, ensuring that results remain comparable across extended studies and collaborative projects. The antibody was raised against a synthetic peptide derived from human RNF20 and purified using affinity chromatography for optimal specificity.
Validation across multiple applications demonstrates this antibody's versatility in the laboratory. Western blot analysis in HeLa and 293 whole cell lysates reveals a clean band at the predicted 114 kDa molecular weight, confirming accurate target recognition at dilutions ranging from 1:500 to 1:5000. Immunohistochemistry studies in paraffin-embedded human testis and melanoma cancer tissues show reliable staining at 1:100 dilution using citrate buffer antigen retrieval. Immunofluorescence analysis in HeLa cells further confirms nuclear localization patterns consistent with RNF20's known chromatin-associated functions.
For cell biology research exploring ubiquitin signaling, epigenetic regulation, or cancer-related pathways, this antibody provides a dependable tool with documented performance across complementary detection methods.
There are currently no reviews for this product.